IMPL insider transactions
Impel Pharmaceuticals Inc. (IMPL) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
IMPL insiders
Everyone who has filed a Form 3, 4, 5 or 144 at Impel Pharmaceuticals Inc., latest first. Follow anyone to get their next filing.
- Brandon D SmithOfficer, since December 2023
- Vivo Capital VIII, LLC10% owner-$74.1K
- BROOKFIELD Corp /ON/10% owner, since November 2023
- Oaktree GCP Fund Delaware Holdings, L.P.10% owner, since November 2023
- David D. AllisonDirector
- Diane E. WilfongDirector
- Mahendra ShahDirector
- Timothy S NelsonDirector+$108K
- Darren S ClineDirector, since April 2023
- Michael Wayne KalbOfficer, since May 2023
- Rajiv AminOfficer, since March 2023
- Leonard PaolilloOfficer
- John HoekmanOfficer
- John Harold LeamanOfficer
- Adrian AdamsOfficer, Director
- H Stewart ParkerDirector, since April 2021
- Stephen B ShrewsburyOfficer
Recent Form 3, 4, and 5 filings for IMPL
- SEC Form 3 filed by new insider Smith Brandon D3 - IMPEL PHARMACEUTICALS INC (0001445499) (Issuer)
- Vivo Capital Viii, Llc sold $74,131 worth of shares (575,000 units at $0.13) (SEC Form 4)4 - IMPEL PHARMACEUTICALS INC (0001445499) (Issuer)
- SEC Form 4 filed by Brookfield Corp /On/4 - IMPEL PHARMACEUTICALS INC (0001445499) (Issuer)
- SEC Form 4 filed by Oaktree Gcp Fund Delaware Holdings, L.P.4 - IMPEL PHARMACEUTICALS INC (0001445499) (Issuer)
- SEC Form 3 filed by new insider Brookfield Corp /On/3 - IMPEL PHARMACEUTICALS INC (0001445499) (Issuer)
- SEC Form 3 filed by new insider Oaktree Gcp Fund Delaware Holdings, L.P.3 - IMPEL PHARMACEUTICALS INC (0001445499) (Issuer)
- SEC Form 4 filed by Allison David D.4 - IMPEL PHARMACEUTICALS INC (0001445499) (Issuer)
- SEC Form 4 filed by Shah Mahendra4 - IMPEL PHARMACEUTICALS INC (0001445499) (Issuer)
- SEC Form 4 filed by Wilfong Diane E.4 - IMPEL PHARMACEUTICALS INC (0001445499) (Issuer)
- SEC Form 4 filed by Nelson Timothy S4 - IMPEL PHARMACEUTICALS INC (0001445499) (Issuer)
- SEC Form 4 filed by Cline Darren S4 - IMPEL PHARMACEUTICALS INC (0001445499) (Issuer)
- SEC Form 4 filed by Kalb Michael Wayne4 - IMPEL PHARMACEUTICALS INC (0001445499) (Issuer)
- SEC Form 3: New insider Kalb Michael Wayne claimed no ownership of stock in the company3 - IMPEL PHARMACEUTICALS INC (0001445499) (Issuer)
- SEC Form 4 filed by Cline Darren S4 - IMPEL PHARMACEUTICALS INC (0001445499) (Issuer)
- SEC Form 3: New insider Cline Darren S claimed no ownership of stock in the company3 - IMPEL PHARMACEUTICALS INC (0001445499) (Issuer)
- SEC Form 3: New insider Amin Rajiv claimed no ownership of stock in the company3 - IMPEL PHARMACEUTICALS INC (0001445499) (Issuer)
- SEC Form 4 filed by Paolillo Leonard4 - IMPEL PHARMACEUTICALS INC (0001445499) (Issuer)
- SEC Form 4 filed by Hoekman John4 - IMPEL PHARMACEUTICALS INC (0001445499) (Issuer)
- SEC Form 4 filed by Leaman John Harold4 - IMPEL PHARMACEUTICALS INC (0001445499) (Issuer)
- SEC Form 4 filed by Adams Adrian4 - IMPEL PHARMACEUTICALS INC (0001445499) (Issuer)
- SEC Form 4: Leaman John Harold converted options into 10,571 shares and covered exercise/tax liability with 3,627 shares to cover taxes4 - IMPEL PHARMACEUTICALS INC (0001445499) (Issuer)
- SEC Form 4 filed by Wilfong Diane E.4 - IMPEL PHARMACEUTICALS INC (0001445499) (Issuer)
- SEC Form 4 filed by Shah Mahendra4 - IMPEL PHARMACEUTICALS INC (0001445499) (Issuer)
- SEC Form 4 filed by Nelson Timothy S4 - IMPEL PHARMACEUTICALS INC (0001445499) (Issuer)
- SEC Form 4 filed by Parker H Stewart4 - IMPEL PHARMACEUTICALS INC (0001445499) (Issuer)
- SEC Form 4 filed by Allison David D.4 - IMPEL PHARMACEUTICALS INC (0001445499) (Issuer)
- SEC Form 4: Shrewsbury Stephen B exercised 24,606 shares at a strike of $1.97, increasing direct ownership by 34% to 97,990 units4 - IMPEL NEUROPHARMA INC (0001445499) (Issuer)
- SEC Form 4 filed by Shrewsbury Stephen B4 - IMPEL NEUROPHARMA INC (0001445499) (Issuer)
- SEC Form 4 filed by Paolillo Leonard4 - IMPEL NEUROPHARMA INC (0001445499) (Issuer)
- SEC Form 4 filed by Leaman John Harold4 - IMPEL NEUROPHARMA INC (0001445499) (Issuer)
- SEC Form 4 filed by Hoekman John4 - IMPEL NEUROPHARMA INC (0001445499) (Issuer)
- SEC Form 4 filed by Adams Adrian4 - IMPEL NEUROPHARMA INC (0001445499) (Issuer)
- SEC Form 4: Hoekman John exercised 20,000 shares at a strike of $1.64, increasing direct ownership by 18% to 128,221 units4 - IMPEL NEUROPHARMA INC (0001445499) (Issuer)
- SEC Form 4: Nelson Timothy S bought $107,554 worth of shares (10,000 units at $10.76)4 - IMPEL NEUROPHARMA INC (0001445499) (Issuer)
- SEC Form 4 filed by Leaman John Harold4 - IMPEL NEUROPHARMA INC (0001445499) (Issuer)
- SEC Form 4: Shrewsbury Stephen B exercised 73,384 units of Common Stock at a strike of $2.724 - IMPEL NEUROPHARMA INC (0001445499) (Issuer)
- SEC Form 4 filed by Impel NeuroPharma Inc.4 - IMPEL NEUROPHARMA INC (0001445499) (Issuer)
- SEC Form 4 filed by SHREWSBURY STEPHEN B4 - IMPEL NEUROPHARMA INC (0001445499) (Issuer)
- SEC Form 4 filed by Impel NeuroPharma Inc.4 - IMPEL NEUROPHARMA INC (0001445499) (Issuer)
- SEC Form 4 filed by Leaman John Harold4 - IMPEL NEUROPHARMA INC (0001445499) (Issuer)
- SEC Form 4 filed by Hoekman John4 - IMPEL NEUROPHARMA INC (0001445499) (Issuer)
- SEC Form 4 filed by ADAMS ADRIAN4 - IMPEL NEUROPHARMA INC (0001445499) (Issuer)
- SEC Form 4 filed by Wilfong Diane E.4 - IMPEL NEUROPHARMA INC (0001445499) (Issuer)
- SEC Form 4 filed by SHAH MAHENDRA4 - IMPEL NEUROPHARMA INC (0001445499) (Issuer)
- SEC Form 4 filed by PARKER H STEWART4 - IMPEL NEUROPHARMA INC (0001445499) (Issuer)
- SEC Form 4 filed by NELSON TIMOTHY S4 - IMPEL NEUROPHARMA INC (0001445499) (Issuer)
- SEC Form 4 filed by Allison David D.4 - IMPEL NEUROPHARMA INC (0001445499) (Issuer)
- SEC Form 4 filed by PARKER H STEWART (Amendment)4/A - IMPEL NEUROPHARMA INC (0001445499) (Issuer)
- SEC Form 3 filed by PARKER H STEWART (Amendment)3/A - IMPEL NEUROPHARMA INC (0001445499) (Issuer)
- SEC Form 4: Hoekman John converted 4,253 units into Common Stock, increasing direct ownership by 4% to 108,496 units (Amendment)4/A - IMPEL NEUROPHARMA INC (0001445499) (Issuer)